Page last updated: 2024-08-23

rimcazole and Neoplasms

rimcazole has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achison, M; Boylan, MT; Hupp, TR; Spruce, BA1

Other Studies

1 other study(ies) available for rimcazole and Neoplasms

ArticleYear
HIF-1alpha contributes to tumour-selective killing by the sigma receptor antagonist rimcazole.
    Oncogene, 2007, Feb-22, Volume: 26, Issue:8

    Topics: Apoptosis; Carbazoles; Cell Line, Tumor; Epithelial Cells; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Pentazocine; Receptors, sigma; RNA Interference; Tumor Suppressor Protein p53; Up-Regulation

2007